申请人:DECIPHERA PHARMACEUTICALS INC
公开号:WO2004060306A2
公开(公告)日:2004-07-22
Novel compounds and methods of using those compounds for the treatment of inflammatory conditions are provided. In a preferred embodiment, modulation of the activation state of p38 kinase protein comprises the step of contacting the kinase protein with the novel compounds.